HR 1781
116th Congress
House
Health
Advisory bodies
Health care costs and insurance
Health information and medical records
Health programs administration and funding
Medicaid
Medicare
Prescription drugs
Payment Commission Data Act of 2019
Introduced: March 14, 2019
Introduced by:
Carter, Earl L. "Buddy"
Republican
· Georgia
See on congress.gov
Everywhere this bill has been
18 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 29, 2019
Received in the Senate and Read twice and referred to the Committee on Finance.
Oct 28, 2019
Motion to reconsider laid on the table Agreed to without objection.
Oct 28, 2019
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H8526)
Oct 28, 2019
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H8526)
Oct 28, 2019
DEBATE - The House proceeded with forty minutes of debate on H.R. 1781.
Oct 28, 2019
Considered under suspension of the rules. (consideration: CR H8526-8527)
Oct 28, 2019
Ms. Schakowsky moved to suspend the rules and pass the bill, as amended.
Oct 28, 2019
Placed on the Union Calendar, Calendar No. 205.
Oct 28, 2019
Committee on Ways and Means discharged.
Oct 28, 2019
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-257, Part I.
Apr 3, 2019
Ordered to be Reported (Amended) by Voice Vote.
Apr 3, 2019
Committee Consideration and Mark-up Session Held.
Mar 27, 2019
Forwarded by Subcommittee to Full Committee by Voice Vote .
Mar 27, 2019
Subcommittee Consideration and Mark-up Session Held.
Mar 15, 2019
Referred to the Subcommittee on Health.
Mar 14, 2019
Referred to the Subcommittee on Health.
Mar 14, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 14, 2019
Introduced in House
Plain-English summary
Payment Commission Data Act of 2019
This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.
What's happening now
Received in the Senate and Read twice and referred to the Committee on Finance.
Committees of jurisdiction
5